Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium

PLoS Pathogens

Volumn 3, Issue 1, 2007, Pages 0075-0096

  Leavis, Helen L ^a,b   Willems, Rob J L ^a   Van Wamel, Willem J B ^a   Schuren, Frank H ^b   Caspers, Martien P M ^b   Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; GENE INSERTION SEQUENCE; GENE SEQUENCE; GENE TRANSFER; GENETIC RECOMBINATION; GENETIC VARIABILITY; HUMAN; HYBRIDIZATION; MICROARRAY ANALYSIS; NONHUMAN; PHYLOGENY; REGULATOR GENE; BACTERIAL GENOME; CLASSIFICATION; DNA MICROARRAY; DRUG EFFECT; GENE REARRANGEMENT; GENETICS; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MOSAICISM; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; TRANSPOSON;

ANIMALIA; ENTEROCOCCUS FAECIUM;

BASE SEQUENCE; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECIUM; EVOLUTION, MOLECULAR; GENE REARRANGEMENT; GENOME, BACTERIAL; MOLECULAR SEQUENCE DATA; MOSAICISM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPEN READING FRAMES; PHYLOGENY; RECOMBINATION, GENETIC;

EID: 33846483575     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0030007     Document Type: Article

References (92)

1. National Nosocomial Infections Surveillance System (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32: 470-485.
2. Murray BE (2000) Vancomycin-resistant enterococcal infections. N Engl J Med 342: 710-721.
3. Endtz HP, van den Braak N, van Belkum A, Kluytmans JA, Koeleman JG, et al. (1997) Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 35: 3026-3031.
4. Stobberingh E, van Den BA, London N, Driessen C, Top J, Willems R (1999) Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: Evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother 43: 2215-2221.
5. van den Bogaard AE, Mertens P, London NH, Stobberingh EE (1997) High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: Is the addition of antibiotics to animal feeds to blame? J Antimicrob Chemother 40: 454-456.
6. van den Braak N, van Belkum A, van Keulen M, Vliegenthart J, Verbrugh HA, et al. (1998) Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands. J Clin Microbiol 36: 1927-1932.
7. van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R (1996) Influence of oral glycopeptides on the fecal flora of human volunteers: Selection of highly glycopeptide-resistant enterococci. J Infect Dis 173: 1129-1136.
8. van Belkum A, van Den BN, Thomassen R, Verbrugh H, Endtz H (1996) Vancomycin-resistant enterococci in cats and dogs. Lancet 348: 1038-1039.
9. Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, et al. (2001) The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 135: 175-183.
10. Centers for Disease Control and Prevention (1995) Recommendations for preventing the spread of vancomycin resistance recommendations of the hospital infection control practices advisory committee (HICPAC). MMWR 44(RR12): 1-13. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/00039349.htm. Accessed 14 December 2006.
11. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, et al. (2006) Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: The effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 166: 306-312.
12. Mascini EM, Troelstra A, Beitsma M, Blok HE, Jalink KP, et al. (2006) Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 42: 739-746.
13. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, et al. (2003) Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348: 1342-1347.
14. Kacica M, McDonald LC (2004) Brief report: Vancomycin-resistant Staphylococcus aureus-New York, 2004. MMWR 53: 322-323.
15. Rudrik JT (2005) Michigan Department of Community Health communication. Available: http://www.michigan.gov/documents/VRSA_Feb05_HAN_118391_7.pdf. Accessed 26 December 2006.
16. Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, et al. (2004) Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 48: 275-280.
17. Klare I, Konstabel C, Mueller-Bertling S, Werner G, Strommenger B, et al. (2005) Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis 24: 815-825.
18. Leavis H, Top J, Shankar N, Borgen K, Bonten M, et al. (2004) A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol 186: 672-682.
19. Rice LB, Carias L, Rudin S, Vael C, Goossens H, et al. (2003) A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 187: 508-512.
20. Willems RJ, Homan W, Top J, van Santen-Verheuvel M, Tribe D, et al. (2001) Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357: 853-855.
21. Homan WL, Tribe D, Poznanski S, Li M, Hogg G, et al. (2002) Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 40: 1963-1971.
22. Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, et al. (2005) Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11: 821-828.
23. Israel DA, Salama N, Krishna U, Rieger UM, Atherton JC, et al. (2001) Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci U S A 98: 14625-14630.
24. Salama N, Guillemin K, McDaniel TK, Sherlock G, Tompkins L, et al. (2000) A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci U S A 97: 14668-14673.
25. Porwollik S, Wong RM, McClelland M (2002) Evolutionary genomics of Salmonella: gene acquisitions revealed by microarray analysis. Proc Natl Acad Sci U S A 99: 8956-8961.
26. Dobrindt U, Agerer F, Michaelis K, Janka A, Buchrieser C, et al. (2003) Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J Bacteriol 185: 1831-1840.
27. Fukiya S, Mizoguchi H, Tobe T, Mori H (2004) Extensive genomic diversity in pathogenic Escherichia coli and Shigella strains revealed by comparative genomic hybridization microarray. J Bacteriol 186: 3911-3921.
28. Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM (2001) Evolutionary genomics of Staphylococcus aureus: Insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci U S A 98: 8821-8826.
29. Fitzgerald JR, Reid SD, Ruotsalainen E, Tripp TJ, Liu M, et al. (2003) Genome diversification in Staphylococcus aureus: Molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins. Infect Immun 71: 2827-2838.
30. Lindsay JA, Moore CE, Day NP, Peacock SJ, Witney AA, et al. (2006) Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol 188: 669-676.
31. Dziejman M, Serruto D, Tam VC, Sturtevant D, Diraphat P, et al. (2005) Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A 102: 3465-3470.
32. Perrin A, Bonacorsi S, Carbonnelle E, Talibi D, Dessen P, et al. (2002) Comparative genomics identifies the genetic islands that distinguish Neisseria meningitidis, the agent of cerebrospinal meningitis, from other Neisseria species. Infect Immun 70: 7063-7072.
33. Yao Y, Sturdevant DE, Villaruz A, Xu L, Gao Q, et al. (2005) Factors characterizing Staphylococcus epidermidis invasiveness determined by comparative genomics. Infect Immun 73: 1856-1860.
34. Akopyants NS, Clifton SW, Martin J, Pape D, Wylie T, Li L, et al. (2001) A survey of the Leishmania major Friedlin strain V1 genome by shotgun sequencing: A resource for DNA microarrays and expression profiling. Mol Biochem Parasitol 113: 337-340.
35. Moore DD (1993) Overview of recombinant DNA libraries. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al., editors. Current protocols in molecular biology. New York: John Wiley & Sons. pp. 5.1.1-5.1.3.
36. Sharp PM, Li WH (1987) The codon adaptation index-A measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res 15: 1281-1295.
37. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
38. Maki H, Murakami K (1997) Formation of potent hybrid promoters of the mutant llm gene by IS256 transposition in methicillin-resistant Staphylococcus aureus. J Bacteriol 179: 6944-6948.
39. McAshan SK, Vergin KL, Giovannoni SJ, Thaler DS (1999) Interspecies recombination between enterococci: Genetic and phenotypic diversity of vancomycin-resistant transconjugants. Microb Drug Resist 5: 101-112.
40. Dorrell N, Mangan JA, Laing KG, Hinds J, Linton D, et al. (2001) Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity. Genome Res 11: 1706-1715.
41. Leavis HL, Willems RJ, Top J, Spalburg E, Mascini EM, et al. (2003) Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg Infect Dis 9: 1108-1115.
42. Willems RJ, Top J, van Den Braak N, van Belkum A, Endtz H, et al. (2000) Host specificity of vancomycin-resistant Enterococcus faecium. J Infect Dis 182: 816-823.
43. Saunders NA, Underwood A, Kearns AM, Hallas G (2004) A virulence-associated gene microarray: A tool for investigation of the evolution and pathogenic potential of Staphylococcus aureus. Microbiology 150: 3763-3771.
44. Stabler RA, Marsden GL, Witney AA, Li Y, Bentley SD, Tang CM, Hinds J (2005) Identification of pathogen-specific genes through microarray analysis of pathogenic and commensal Neisseria species. Microbiology 151: 2907-2922.
45. Eisen JA, Benito MI, Walbot V (1994) Sequence similarity of putative transposases links the maize mutator autonomous element and a group of bacterial insertion sequences. Nucleic Acids Res 22: 2634-2636.
46. Quintiliani R Jr., Courvalin P (1996) Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene 172: 1-8.
47. Naas T, Fortineau N, Snanoudj R, Spicq C, Durrbach A, Nordmann P (2005) First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. J Clin Microbiol 43: 3642-3649.
48. Dahl KH, Lundblad EW, Rokenes TP, Olsvik O, Sundsfjord A (2000) Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-resistant enterococci and characterization of two novel insertion sequences. Microbiology 146 ( Pt 6): 1469-1479.
49. Grady R, Hayes F (2003) Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol Microbiol 47: 1419-1432.
50. Yang F, Yang J, Zhang X, Chen L, Jiang Y, et al. (2005) Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res 33: 6445-6458.
51. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR (2005) Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 1: e45.
52. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, et al. (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35: 32-40.
53. Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, et al. (2003) Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299: 2071-2074.
54. Werner G, Hildebrandt B, Witte W (2003) Linkage of erm(B) and aadE-sat4-aphA-3 in multiple-resistant Enterococcus faecium isolates of different ecological origins. Microb Drug Resist 9 Suppl 1: S9-16.
55. Werner G, Hildebrandt B, Witte W (2001) Aminoglycoside-streptothricin resistance gene cluster aadE-sat4-aphA-3 disseminated among multiresistant isolates of Enterococcus faecium. Antimicrob Agents Chemother 45: 3267-3269.
56. Champion OL, Gaunt MW, Gundogdu O, Elmi A, Witney AA, Hinds J, Dorrell N, Wren BW (2005) Comparative phylogenomics of the food-borne pathogen Campylobacter jejuni reveals genetic markers predictive of infection source. Proc Natl Acad Sci U S A 102: 16043-16048.
57. Howard SL, Gaunt MW, Hinds J, Witney AA, Stabler R, Wren BW (2006) Application of comparative phylogenomics to study the evolution of Yersinia enterocolitica and to identify genetic differences relating to pathogenicity. J Bacteriol 188: 3645-3653.
58. Melles DC, Gorkink RF, Boelens HA, Snijders SV, Peeters JK, et al. (2004) Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 114: 1732-1740.
59. Pupo GM, Lan R, Reeves PR (2000) Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proc Natl Acad Sci U S A 97: 10567-10572.
60. Helgason E, Okstad OA, Caugant DA, Johansen HA, Fouet A, et al. (2000) Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis- One species on the basis of genetic evidence. Appl Environ Microbiol 66: 2627-2630.
61. Groisman EA, Ochman H (1996) Pathogenicity islands: Bacterial evolution in quantum leaps. Cell 87: 791-794.
62. Sokurenko EV, Hasty DL, Dykhuizen DE (1999) Pathoadaptive mutations: Gene loss and variation in bacterial pathogens. Trends Microbiol 7: 191-195.
63. Rose M, Charlesworth B (1980) A test of evolutionay theories of senescence. Nature 287: 141-142.
64. Bonten MJ, Hayden MK, Nathan C, van Voorhis J, Matushek M, et al. (1996) Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348: 1615-1619.
65. Bonten MJ, Hayden MK, Nathan C, Rice TW, Weinstein RA (1998) Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis 177: 378-382.
66. Dunne WM Jr, Wang W (1997) Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan. J Clin Microbiol 35: 388-392.
67. Jordens JZ, Bates J, Griffiths DT (1994) Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 34: 515-528.
68. Mohn SC, Ericson Solid JU, Jureen R, Steen VM, Langeland N (2005) Novel insertion sequence between the pbp5 and psr genes is associated with ampicillin resistance in Enterococcus faecium [dissertation].
69. Timmers GJ, van der Zwet WC, Simoons-Smit IM, Savelkoul PH, Meester HH, et al. (2002) Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: Risk factor assessment and successful control of the epidemic. Br J Haematol 116: 826-833.
70. Arduino RC, Murray BE, Rakita RM (1994) Roles of antibodies and complement in phagocytic killing of enterococci. Infect Immun 62: 987-993.
71. Woodford N, Soltani M, Hardy KJ (2001) Frequency of esp in Enterococcus faecium isolates. Lancet 358: 584.
72. Henwood CJ, Livermore DM, Johnson AP, James D, Warner M, et al. (2000) Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group. J Antimicrob Chemother 46: 931-940.
73. Willems RJ, Top J, van Den Braak N, van Belkum A, Mevius DJ, et al. (1999) Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 43: 483-491.
74. Borucki MK, Kim SH, Call DR, Smole SC, Pagotto F (2004) Selective discrimination of Listeria monocytogenes epidemic strains by a mixed-genome DNA microarray compared to discrimination by pulsed-field gel electrophoresis, ribotyping, and multilocus sequence typing. J Clin Microbiol 42: 5270-5276.
75. Aymerich T, Holo H, Havarstein LS, Hugas M, Garriga M, et al. (1996) Biochemical and genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial bacteriocin in the pediocin family of bacteriocins. Appl Environ Microbiol 62: 1676-1682.
76. Bozdogan B, Berrezouga L, Kuo MS, Yurek DA, Farley KA, et al. (1999) A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob Agents Chemother 43: 925-929.
77. Dutka-Malen S, Evers S, Courvalin P (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33: 1434.
78. Eaton TJ, Gasson MJ (2001) Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 67: 1628-1635.
79. Fines M, Perichon B, Reynolds P, Sahm DF, Courvalin P (1999) VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 43: 2161-2164.
80. Gevers D, Danielsen M, Huys G, Swings J (2003) Molecular characterization of tet(M) genes in Lactobacillus isolates from different types of fermented dry sausage. Appl Environ Microbiol 69: 1270-1275.
81. Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, et al. (1999) A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 44: 19-25.
82. Min YH, Jeong JH, Choi YJ, Yun HJ, Lee K, et al. (2003) Heterogeneity of macrolide-lincosamide-streptogramin B resistance phenotypes in enterococci. Antimicrob Agents Chemother 47: 3415-3420.
83. Soltani M, Beighton D, Philpott-Howard J, Woodford N (2000) Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe. Antimicrob Agents Chemother 44: 433-436.
84. Teng F, Kawalec M, Weinstock GM, Hryniewicz W, Murray BE (2003) An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth. Infect Immun 71: 5033-5041.
85. Vakulenko SB, Donabedian SM, Voskresenskiy AM, Zervos MJ, Lerner SA, et al. (2003) Multiplex PCR for detection of aminoglycoside resistance genes in enterococci. Antimicrob Agents Chemother 47: 1423-1426.
86. Vankerckhoven V, Van Autgaerden T, Vael C, Lammens C, Chapelle S, et al. (2004) Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol 42: 4473-4479.
87. Werner G, Hildebrandt B, Witte W (2001) The newly described msrC gene is not equally distributed among all isolates of Enterococcus faecium. Antimicrob Agents Chemother 45: 3672-3673.
88. Xu Y, Singh KV, Qin X, Murray BE, Weinstock GM (2000) Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. Infect Immun 68: 815-823.
89. Nallapareddy SR, Weinstock GM, Murray BE (2003) Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol 47: 1733-1747.
90. Ronquist F, Huelsenbeck JP (2003) MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19: 1572-1574.
91. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 57: 289-300.
92. Holmes EC, Urwin R, Maiden MC (1999) The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis. Mol Biol Evol 16: 741-749.